2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

Thread starter U.S. News
Start date Jan 10, 2026

U.S. News

Guest

Jan 10, 2026

Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

Prefix: N/A

Forum: USA News

Start date: Jan 10, 2026

Last reply date: Jan 10, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Jan 10, 2026

Replies: 0

Views: 6

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search